Neuronal activity and early neurofibrillary tangles in Alzheimer's disease

Annals of Neurology

Volumn 40, Issue 3, 1996, Pages 411-420

  Hatanpää, Kimmo ^a,b   Brady, Daniel R ^a   Stoll, James ^a   Rapoport, Stanley I ^a   Chandrasekaran, Krish ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; MESSENGER RNA; RIBOSOME RNA;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; BRAIN MITOCHONDRION; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NERVE CELL; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

EID: 0029811758     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400310     Document Type: Article

References (58)

1. Haxby JV. Resting state regional cerebtal metabolism in dementia of the Alzheimer type. In: Duara R, ed. Positron emission tomography in dementia. New York: Wiley-Liss, 1990:93-116
2. Mielke R, Herholz K, Grond M, et al. Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia 1994;5:36-41
3. Grady CL, Haxby JV, Horwitz B. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 1988; 10:576-596
4. Hof PR, Cox K, Morrison JH. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J Comp Neurol 1990;301:44-54
5. Masliah E, Miller A, Terry RD. The synaptic organization of the neocortex in Alzheimer's disease. Med Hypotheses 1993; 41:334-340
6. DeCarli C, Atack J, Ball M, et al. Post-mortem regional neuro-fibrillary tangle densities, but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients. Neurodegeneration 1992; 1:11-20
7. Wong-Riley MT. Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res 1979;171:11-28
8. Wong-Riley MT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 1989;12: 94-101
9. Hevner RF, Wong-Riley MT. Regulation of cytochrome oxidase protein levels by functional activity in the Macaque monkey visual system. J Neurosci 1990;10:1331-1340
10. Hevner RF, Wong-Riley MT. Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons. J Neurosci 1993;13:1805-1819
11. Borowsky IW, Collins RC. Metabolic anatomy of brain: a comparison of regional capillary density, glucose metabolism, and enzyme activities. J Comp Neurol 1989;288:401-413
12. Hevner RF, Wong-Riley MT. Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J Neurosci 1991;11:1942-1958
13. Hevner RF, Liu S, Wong-Riley MT. A metabolic map of cytochrome oxidase in the rat brain: histochemical, densitometric and biochemical studies. Neuroscience 1995;65:313-342
14. Kish SJ, Bergeron C, Rajput A. Brain cytochrome oxidase in Alzheimer's disease. J Neurochem 1992;59:776-779
15. Chandrasekaran K, Giordano T, Brady DR, et al. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res Mol Brain Res 1994;24:336-340
16. Mutisya EM, Bowling AC, Beal MF. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 1994;63:2179-2184
17. Sheu KFR, Kim YT, Blass JP, Weksler ME. An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann Neurol 1985;17:444-449
18. Gibson GE, Sheu KF, Blass JP, et al. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol 1988; 45:836-840
19. Mastrogiacomo F, Bergeron C, Kish SJ. Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. J Neurochem 1993;61:2007-2014
20. Parker WD, Parks J, Filley CM, Kleinschmidt-DeMasters BK. Electron transport chain defects in Alzheimer's disease brain. Neurology 1994;44:1090-1096
21. Fukuyama R, Fu J, Hatanpää K, et al. Gene expression of ND4, a mitochondrial DNA-encoded subunit of NADH dehydrogenase, is decreased in neurons of Alzheimer's disease brain. Soc Neurosci Abstr 1995;21:1725
22. Parnetti L, Gaiti A, Brunetti M, et al. Increased CSF pyruvate levels as a marker of impaired energy metabolism in Alzheimer's disease. J Am Geriatr Soc 1995;43:316-318 (Letter)
23. Perry EK, Atack JR, Perry RH, et al. Intralaminar neurochemical distributions in human midtemporal cortex: comparison between Alzheimer's disease and the normal. J Neurochem 1984; 42:1402-1410
24. Liguri G, Taddei N, Nassi P, et al. Changes in Na+, K+-ATPase, Ca2+-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease. Neurosci Lett 1990;112:338-342
25. Coleman PD. Toward rational therapy for Alzheimer's disease. Neurobiol Aging 1994;15(suppl 2):S77-S78
26. Lee VM, Daughenbaugh R, Trojanowski JQ. Microtubule stabilizing drugs for the treatment of Alzheimer's disease. Neurobiol Aging 1994;15(suppl 2):S87-S89
27. Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 1992;31:119-130
28. Robakis NK, Pangalos MN. Involvement of amyloid as a central step in the development of Alzheimer's disease. Neurobiol Aging 1994;15(suppl 2):S127-S129
29. Ginsberg L, Atack JR, Rapoport SI, Gershfeld NL. Evidence for a membrane lipid defect in Alzheimer disease. Mol Chem Neuropathol 1993;19:37-46
30. Ginsberg L, Atack JR, Rapoport SI, Gershfeld NL. Regional specificity of membrane instability in Alzheimer's disease brain. Brain Res 1993;615:355-357
31. Vickers JC, Delacourte A, Morrison JH. Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease. Brain Res 1992;594:273-278
32. Benzing WC, Ikonomovic MD, Brady DR, et al. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease. J Comp Neurol 1993;334:176-191
33. Hatanpää K, Brady DR, Stoll J, Chandrasekaran K. Cytochrome oxidase subunit mRNA in paired helical filament-immunoreactive neurons in Alzheimer's disease. Soc Neurosci Abstr 1995;21:739
34. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. Arch Pathol Lab Med 1993;117:132-144
35. Chandrasekaran K, Stoll J, Giordano T, et al. Differential expression of cytochrome oxidase (COX) genes in different regions of monkey brain. J Neurosci Res 1992;32:415-423
36. Gentleman SM, Roberts GW. Immunocytochemistry: a neuropathological perspective. Appendix: immunostaining protocol. In: Roberts GW, Polak JM, eds. Molecular neuropathology. Cambridge, England: Cambridge University Press, 1995: 72
37. Greenberg SG, Davies P, Schein JD, Binder LI. Hydrofluoric acid-treated tau-PHF proteins display the same biochemical properties as normal tau. J Biol Chem 1992;267:564-569
38. Otvos L, Feiner L, Lang E, et al. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 1994;39:669-673
39. Abacus Concepts. Statview. Berkeley, CA: Abacus Concepts, 1992
40. Neter J, Wasserman W, Kutner MH. Applied linear statistical models. Homewood, IL: Richard D. Irwin, 1985:981-983
41. Keppel G. Design and analysis. Englewood Cliffs, NJ: Prentice-Hall, 1982:482-515
42. Masliah E, Ellisman M, Carragher B, et al. Three dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease. J Neuropathol Exp Neurol 1992;51:404-414
43. Wallace DC, Shoffner JM, Trounce I, et al. Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim Biophys Acta 1995;1271:141-151
44. Corral-Debrinski M, Horton T, Lott MT, et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 1994;23:471-476
45. Suomalainen A, Kaukonen J, Amati P, et al. An autosomal locus predisposing to deletions of mitochondrial DNA. Nature Genet 1995;9:146-151
46. Suomalainen A, Majander A, Haltia M, et al. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest 1992;90:61-66
47. Kaukonen JA, Amati P, Suomalainen A, et al. An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p. Am J Hum Genet 1996;58:763-769
48. Hayashi J, Ohta S, Kagawa Y. Nuclear but not mitochondrial genome involvement in human age-related mitochondrial dysfunction. J Biol Chem 1994;269:6878-6883
49. Heddi A, Lestienne P, Wallace DC, Stepien G. Mitochondrial DNA expression in mitochondrial myopathies and coordinated expression of nuclear genes involved in ATP production. J Biol Chem 1993;268:12156-12163
50. Simonian NA, Hyman BT. Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. J Neuropathol Exp Neurol 1994;53:508-512
51. Su JH, Cummings BJ, Cotman CW. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Neuroreport 1994;5:2358-2362
52. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol (Berl) 1994;87:554-567
53. De Boni U, McLachlan DR. Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons by glutamate and aspartate. J Neurol Sci 1985;68:105-118
54. Sindou P, Couratier P, Barthe D, Hugon J. A dose-dependent increase of tau immunostaining is produced by glutamate toxicity in primary neuronal cultures. Brain Res 1992;572:242-246
55. Colombari E, Talman WT. Denervation supersensitivity to glutamate in the nucleus tractus solitarii after removal of the nodose ganglion. Brain Res 1995;677:110-116
56. Alonso ADC, Zaidi T, Grundke-Iqbal I, Iqbal K. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer's disease. Proc Natl Acad Sci USA 1994;91: 5562-5566
57. Martinez M, Ferrandiz ML, De Juan E, Miquel J. Age-related changes in glutathione and lipid peroxide content in mouse synaptic mitochondria: relationship to cytochrome c oxidase decline. Neurosci Lett 1994;170:121-124
58. Masliah E, Mallory M, Hansen L, et al. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 1993;43:192-197